BioCatalyst

T3011, T3011 + pembrolizumab — catalyst calendar

1 verified catalyst event(s) referencing T3011, T3011 + pembrolizumab, each linked to its official source. Verified as of 2026-06-22.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-09-22
in 3mo
ESTIMATED
 READOUT
A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and i
Phase 1/2 · Solid Tumor, Melanoma
 ImmVira Pharma Co. Ltd T3011, T3011 + pembrolizumab ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.